换一批XANTUS-EL: A real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation in Eastern Europe, Middle East, Africa and Latin America.
第一单位：
Department of Interventional Cardiology, General Hospital "Dr Miguel Silva", Morelia, Michoacán, Mexico.
作者：
关键词
AE, adverse eventAF, atrial fibrillationCI, confidence intervalCNS, central nervous systemCrCl, creatinine clearanceEEMEAEEMEA, Eastern Europe the Middle East and AfricaISTH, International Society on Thrombosis and HaemostasisLatin AmericaMI, myocardial infarctionNOAC, non-vitamin K antagonist oral anticoagulantNVAF, non-valvular atrial fibrillationPE, pulmonary embolismReal-worldRivaroxabanSAE, serious adverse eventSD, standard deviationSE, systemic embolismStroke preventionTIA, transient ischaemic attackVKA, vitamin K antagonistod, once daily
DOI
10.1016/j.ehj.2018.09.002
PMID
30591748
发布时间
2022-03-30
- 浏览7
The Egyptian heart journal
2018年70卷4期
307-313页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
